# Nolato > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/nolato). ## Overview Nolato is a Swedish industrial group that develops and manufactures polymer-based products and components for selected end markets. Its business combines design support, tooling, and high-volume production across a decentralized structure with operations in Europe, Asia, and North America. ## Products & services • Polymer components and customized plastic parts • Silicone and elastomer-based products • Design-for-manufacturing and project development • High-volume contract manufacturing • Assembly and packaging of customer-specific solutions - **Medical Solutions** (50%) — Customized polymer-based products and components for healthcare and medtech applications. - **Engineered Solutions** (50%) — Technical polymer components and assemblies for industrial and consumer end markets. - Polymer components and customized plastic parts - Silicone and elastomer-based products - Design-for-manufacturing and project development - High-volume contract manufacturing - Assembly and packaging of customer-specific solutions ## Customers Nolato sells mainly to large industrial customers that outsource development and production of polymer components. End markets include healthcare, medtech, consumer products, and general industry, with products often becoming key components in the customer’s finished goods. The company works early in the design process and then supports customers through tooling, industrialization, and volume production. - **Medical Solutions customers** (primary) — Healthcare and medtech companies buying customized polymer components and assemblies for regulated applications. - **Engineered Solutions industrial customers** (primary) — Industrial OEMs buying technical polymer parts, often for outsourced production and design support. - **Consumer and branded product companies** (secondary) — Companies sourcing plastic, silicone, and elastomer parts for finished consumer products. - Large OEMs outsourcing polymer component design and production - Medtech and healthcare customers needing regulated components - Industrial customers seeking technical parts and assemblies - Consumer-product brands using customized plastic and silicone parts - Customers that value early design support and supply-chain proximity ## Geography Nolato has a global production footprint with manufacturing on three continents and a strong presence in Europe, Asia, and North America. The company emphasizes regional proximity to customers and suppliers, which supports shorter logistics chains, faster decision-making, and resilience in supply disruptions. Reported lease exposure also points to production premises in China, the UK, and Sweden. - **Europe** (45%) — Estimated from the company's stated strong presence in Europe. - **Asia** (30%) — Estimated from the company's stated manufacturing presence in Asia. - **North America** (25%) — Estimated from the company's stated manufacturing presence in North America. - Manufacturing and customer support across Europe, Asia, and North America - Regional production helps serve customers close to their end markets - Global footprint reduces logistics distance and supply-chain dependence - Production premises are notably present in China, the UK, and Sweden ## Strategy Nolato’s strategy is to be a long-term partner for customers in Medical Solutions and Engineered Solutions, combining design expertise with high-volume production. The company focuses on customer-centric growth, expansion in priority markets, and deeper involvement in the value chain through sustainable, end-to-end solutions. - **Grow with large customers in selected end markets** (medium-term) — Large OEM relationships can create repeat volumes and support long-term platform growth. - **Expand regional production close to customers** (medium-term) — Local manufacturing improves service, logistics, and resilience in disrupted supply chains. - **Increase value-added engineering content** (long-term) — Design-for-manufacturing and project expertise help differentiate Nolato from pure contract manufacturers. - Focus on Medical Solutions and Engineered Solutions - Win large customers in growth-oriented end markets - Expand through regional proximity and customer follow-on business - Strengthen design, project management, and lean manufacturing - Position sustainability as part of product development and customer value ## Risks Nolato is exposed to customer concentration, subcontracting dependence, and cyclical demand in industrial end markets, while medical-related operations are typically more resilient. The company also faces input-cost, production, cybersecurity, and foreign-exchange risks because it operates a global manufacturing network and relies on specialized materials and suppliers. - **Customer dependence** [high] — Nolato depends on customer programs, volumes, and product lifecycles in outsourced manufacturing. - **Business cycle risk** [high] — Engineered Solutions is tied to industrial demand and broader manufacturing cycles. - **Raw material price risk** [medium] — Polymer, silicone, elastomer, and related input costs can move quickly and affect margins. - **Foreign exchange risk** [medium] — The company operates across multiple currencies and geographies. - **Cybersecurity incidents** [medium] — A global manufacturing and customer-data environment increases operational and data-security exposure. - Customer dependence can affect volumes if key programs are delayed or canceled - Supplier and subcontractor failures can disrupt delivery and quality - Raw material, energy, and FX swings can pressure operating performance - Production interruptions and product liability are material in component manufacturing - Cybersecurity and geopolitical trade barriers can affect global operations ## Accounting Nolato’s reporting is shaped by lease accounting, estimates for provisions and contingencies, and foreign-currency translation across a multi-country manufacturing base. Investors should also watch how revenue is recognized in customized production programs, how inventories and working capital move with demand, and whether goodwill or intangible assets require impairment testing in acquired businesses. - **IFRS 16 lease accounting** — Right-of-use assets and lease liabilities - **Revenue recognition on customized contracts** — Revenue and margin timing - **Inventory valuation** — Gross profit and working capital - **Provisions and contingent liabilities** — Operating expenses and liabilities - IFRS 16 leases affect reported assets, liabilities, and operating costs - Revenue timing depends on customized production and delivery terms - Inventory valuation matters in polymer manufacturing and demand swings - Provisions and contingent liabilities affect legal, warranty, and liability risk - FX translation affects reported results across multiple currencies --- *Last updated: 2026-08-11T04:04:54.904324+00:00*